NIAID Site Search

Showing results filtered by:
Clear All
BREAKS
host
35 Results

NIAID Biodefense Research Agenda for CDC Category A Agents - 2006 Progress Report

https://www.niaid.nih.gov/sites/default/files/cata_2006.pdf
PDF Document | 909.05 KB
This document provides a progress report about the Biodefense Research Agenda for CDC Category A Agents in 2006.

Last Reviewed: August 6, 2019

Suk See De Ravin, M.D., Ph.D.

Genetic Immunotherapy Section
Gene therapy Inborn Errors of Immunity/Primary Immunodeficiency Diseases; Chronic Granulomatous Disease, X-linked Severe Combined Immunodeficiency, XMEN, WHIM, XLA, STAT3, STAT1, CTLA4.

Last Reviewed: August 10, 2022

NIAID Biodefense Research Agenda for CDC Category A Agents - Progress Report August 2003

https://www.niaid.nih.gov/sites/default/files/category_a_progress_report.pdf
PDF Document | 676.04 KB
This document provides a progress report about the Biodefense Research Agenda for CDC Category A Agents in August 2003.

Last Reviewed: August 6, 2019

Sample application (R15): Mohammad Ayoub Mir

https://www.niaid.nih.gov/sites/default/files/R15-Mohammad-Ayoub-Mir-Application.pdf
PDF Document | 1.62 MB
Sample application from Mohammad Ayoub Mir

Last Reviewed: August 4, 2017

Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002

https://www.niaid.nih.gov/sites/default/files/jordan20_2002.pdf
PDF Document | 5.65 MB
Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

Strategic Plan and Research Agenda for Medical Countermeasures Against Radiological and Nuclear Threats Progress Report: 2005–2011 and Future Research Directions: 2012–2016

https://www.niaid.nih.gov/sites/default/files/radnucprogressreport.pdf
PDF Document | 527.85 KB
2021 progress report on NIH strategic plan to develop medical countermeasures against possible terrorist attacks involving radioactive materials.

Last Reviewed: December 30, 2016

Myles Research Group

Epithelial Therapeutics Unit
Epithelial Therapeutics Unit – work on the interface of environment, the microbiome, and allergic disease

Last Reviewed: September 26, 2022

Sample Applications & More

A collection of sample grant applications and other resources provided by NIAID investigators.

Last Reviewed: November 6, 2024

NIAID Council Minutes January 30, 2023

The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and

Last Reviewed: February 5, 2024

NIAID Council Minutes September 11, 2023

The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public

Last Reviewed: January 11, 2024